Abstract
In metabolic dysfunction–associated steatohepatitis (MASH), liver sinusoidal endothelial cells (LSECs) acquire a proinflammatory phenotype termed lipotoxic endotheliopathy. We previously identified glycogen synthase kinase 3β (GSK3β) as a central signaling hub in LSECs during MASH. To elucidate the molecular mechanisms and functional outcome of lipotoxicity-induced GSK3β activation in LSECs, we utilized endothelial cell–specific Gsk3β-KO (Gsk3βΔEnd) mice fed MASH-inducing diets. Endothelial Gsk3β deletion significantly reduced markers of lipotoxic endotheliopathy, including adhesion molecules and chemokines, alongside liver injury, inflammation, and fibrosis. Immune profiling via flow cytometry and mass cytometry by time of flight (CyTOF) identified decreased hepatic infiltration of proinflammatory myeloid populations, particularly mature DCs in Gsk3βΔEnd mice. In a coculture system, GSK3β in lipotoxic LSECs promoted DCs maturation. Mechanistically, GSK3 inhibition restored lipotoxicity-induced alterations in LSEC mitochondrial morphology and respiration by regulating AMP-activated protein kinase and dynamin-related protein 1. This rescue suppressed chemokine and adhesion molecule expression, thereby limiting immune cell recruitment. Collectively, under lipotoxic stress, GSK3β amplifies mitochondrial dysfunction and inflammatory signaling in LSECs, enhancing myeloid cell homing and DC maturation. Targeting LSEC GSK3β may, therefore, represent a promising therapeutic strategy to mitigate LSEC-driven fibroinflammatory response in human MASH.
Authors
Akitoshi Sano, Qianqian Guo, Khaled Warasnhe, Chady Meroueh, Nantawat Satthawiwat, Asma Hamdi, Ghefar Hmaydoosh, Xin Dai, Usman Yaqoob, Kevin D. Pavelko, Charlene Miciano, Tatiana Kisseleva, Zeba Firdaus, Patrick P. Starlinger, David Pereyra, Enis Kostallari, Petra Hirsova, Davide Povero, Samar H. Ibrahim
Figure 5
GSK3β inhibition attenuates the LSEC proinflammatory phenotype and upregulates AMPK pathway in lipotoxicity and murine MASH.
